2026 CCLSA Webinar - Save Sight Dry Eye Registry, Dry Eye & Ocular Surface
Date: 27/09/2026 ()
Venue: Online - Zoom, AUSTRALIA
Provider: Cornea & Contact Lens Society of Australia
Contact: CCLSA Secretary, [E] info@cclsa.org.au, [P] 02 9431 8676
Activity Outline
What you need to know about the Save Sight Dry Eye Registry
The latest insights on Dry Eye
The good, the bad and the ugly of managing meibomian gland dysfunction
Beyond Lubrication: Optimising Dry Eye Management
with High Molecular Weight 0.4% Sodium Hyaluronate
Managing Dry Eye and Inflammation in Practice and using the Save Sight Registry
Sponsor Presentation
Panel, Q&A & Live Polling
Learning Objectives
- Understand real world data and Save Sight Dry Eye Registry Key insights into the real world of dry eye What can be learnt from dry eye data
- Sharing Core Values & Mission: Meet the Company & People Understand the latest clinical & research and insights
- How long do MGD treatments last? Which patients do better and how can we optimise treatments for success? Is there a role for management of MGD in contact lens discomfort? Should we consider prevention to limit symptomatic disease and what are the best endpoints to use clinically? What do patients most want to know (but might be afraid to ask....)?
- Understanding ocular Inflammation & the ocular surface Research insights and evidence Clinical management of ocular surface inflammation
- 1. Explain the scientific rationale for using higher molecular weight sodium hyaluronate in dry eye disease, including its effects on tear film stability, ocular surface lubrication, epithelial protection and patient comfort.
- 2. Identify which dry eye phenotypes and clinical scenarios are most likely to benefit from higher molecular weight sodium hyaluronate, including evaporative dry eye, aqueous deficient dry eye, contact lens wear, post-operative care and inflammatory ocular surface disease.
- 3. Develop practical treatment strategies incorporating higher molecular weight sodium hyaluronate within a staged dry eye management plan alongside anti-inflammatory therapy, lid management, environmental modification and long-term patient follow-up.
- Sharing of Clinical Tips & Techniques Addressing Q&A from delegates and FAQs Interactive Panel Discussion from our Presenters
Max CPD hours awarded: 1.5
Session Information
| Name |
|---|
| The Save Sight Dry Eye Registry: Key facts and Data |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |
| Name |
|---|
| The good, the bad and the ugly of managing meibomian gland dysfunction |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |
| Name |
|---|
| Beyond Lubrication: Optimising Dry Eye Management with High Molecular Weight 0.4% Sodium Hyaluronate |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |